After FDA's approval, the company seems nowhere to be successful. How do they launch the product? GIA? The company needs to raise cash by dilution. Partner? Who is interesting in this low-profile product? The existing cash is only enough to run current operation for one more year, not even to mention developing the next product.
Great questions. The company will be stagnant until outside help arrives. Due to the current financial environment, companies may be a tad bit stingy loaning large amounts of cash and resources to a company that does not seem to spend it well.